Luo et al. [38] studied the relationship between miR-216b, autophagy and vemurafenib in melanoma cells harboring a V600E mutation in the BRAF gene; vemurafenib-sensitive A375 and G-361 cell lines, as well as vemurafenib-resistant G-361-R and A375-R cells, were utilized in these studies. Here, BRAF is linked to melanoma.